Gender | Age | Site | Dose | Time of Use | Systemic Disease | Treatment |
Feminine | 64 | Palate | 200 mg/day Chloroquine | 15 yrs. | Arterial hypertension and rheumatoid arthritis | Incisional biopsy |
Feminine | 55 | Mandibular Gingiva | 200 mg/day Hydroxychloroquine | 8 months | Sjogren’s syndrome | Incisional biopsy |
Feminine | 53 | Palate | 400 mg/day Hydroxychloroquine | 5 yrs. | Arterial hypertension and rheumatoid arthritis | Incisional biopsy and discontinuation of medication |
Feminine | 40 | Palate | 250 mg/day Chloroquine | 2 yrs. | Rheumatoid arthritis | Incisional biopsy—drug replacement with leflunomide 20 mg/day |
Feminine | 50 | Palate | 250 mg/day Chloroquine | 4 yrs. | Rheumatoid arthritis | Incisional biopsy and discontinuation of medication |
Feminine | 66 | Palate | 250 mg/day Chloroquine | 3 yrs. | Rheumatoid arthritis | Incisional biopsy and clinical follow-up |
Feminine | 60 | Palate | 150 mg/day Chloroquine | 1 yr. | Rheumatoid arthritis | Incisional biopsy and discontinuation of medication |